Abstract
Amblyopia therapy options have traditionally been limited to penalisation of the non-amblyopic eye with either patching or pharmaceutical penalisation. Solid evidence, mostly from the Pediatric Eye Disease Investigator Group, has...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have